-
Je něco špatně v tomto záznamu ?
Self-assembly of carrageenin–CaCO3 hybrid microparticles on bacterial cellulose films for doxorubicin sustained delivery
Maximiliano L. Cacicedo, Karina Cesca, Valeria E. Bosio, Luismar M. Porto, Guillermo R. Castro
Jazyk angličtina Země Česko
Typ dokumentu práce podpořená grantem
- MeSH
- antitumorózní látky aplikace a dávkování terapeutické užití toxicita MeSH
- bakteriální polysacharidy biosyntéza farmakologie metabolismus MeSH
- biomedicínský výzkum metody trendy MeSH
- celulosa * biosyntéza farmakologie MeSH
- doxorubicin aplikace a dávkování farmakologie MeSH
- elektronová mikroskopie metody využití MeSH
- Gluconacetobacter růst a vývoj účinky léků MeSH
- individualizovaná medicína metody trendy využití MeSH
- karagenan * biosyntéza metabolismus MeSH
- konfokální mikroskopie metody využití MeSH
- lidé MeSH
- nanokompozity chemie mikrobiologie využití MeSH
- spektrofotometrie infračervená metody využití MeSH
- statistika jako téma metody MeSH
- systémy cílené aplikace léků metody využití MeSH
- techniky in vitro MeSH
- uhličitan vápenatý * chemická syntéza metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
Stereospecific nucleation of mesoporous hybrid microspheres composed of CaCO3 and carrageenan was appended to one side of bacterial cellulose membrane synthesized in static cultures of Gluconacetobacter hansenii to develop an implantable drug delivery device. The synthesis of the hybrid microparticles proceeds by self-assembly mechanism in the presence of calcium and contains tailorable amounts of doxorubicin. However, in the absence of the particles, doxorubicin was distributed along the BC film, but without control release of drug. Infrared spectroscopy, confocal and scanning electron microscopies analyses demonstrate that the doxorubicin is entrapped inside the hybrid particles with approximately 80% drug loading compared to the 11% obtained for native bacterial cellulose. Doxorubicin content in the hybrid particles can be increased by a factor of 10 (from 258.6 to 2586.3 nmol ml−1), and also by the quantities of particles regulated by the CaCO3–carrageenan content and the physicochemical microenvironment. The hybrid BC system can be considered as smart device since the kinetic release of doxorubicin from the hybrid cellulose system rise from 1.50 to 2.75 μg/membrane/day when the pH decreases from 7.4 to 5.8 at 37 °C, a pathologic simulated environment. The hybrid microparticle system can be potentially used as an implantable drug delivery system for personalized oncological therapies.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15030073
- 003
- CZ-PrNML
- 005
- 20160131150241.0
- 007
- ta
- 008
- 150922s2015 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2015.03.004 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Cacicedo, Maximiliano L. $u Nanobiomaterials Laboratory, Institute of Applied Biotechnology (CINDEFI, CONICET CCT La Plata), Department of Chemistry, School of Sciences, Universidad Nacional de La Plata, Calle 47 y 115, CP 1900, Ciudad de La Plata, Argentina
- 245 10
- $a Self-assembly of carrageenin–CaCO3 hybrid microparticles on bacterial cellulose films for doxorubicin sustained delivery / $c Maximiliano L. Cacicedo, Karina Cesca, Valeria E. Bosio, Luismar M. Porto, Guillermo R. Castro
- 504 __
- $a Literatura
- 520 9_
- $a Stereospecific nucleation of mesoporous hybrid microspheres composed of CaCO3 and carrageenan was appended to one side of bacterial cellulose membrane synthesized in static cultures of Gluconacetobacter hansenii to develop an implantable drug delivery device. The synthesis of the hybrid microparticles proceeds by self-assembly mechanism in the presence of calcium and contains tailorable amounts of doxorubicin. However, in the absence of the particles, doxorubicin was distributed along the BC film, but without control release of drug. Infrared spectroscopy, confocal and scanning electron microscopies analyses demonstrate that the doxorubicin is entrapped inside the hybrid particles with approximately 80% drug loading compared to the 11% obtained for native bacterial cellulose. Doxorubicin content in the hybrid particles can be increased by a factor of 10 (from 258.6 to 2586.3 nmol ml−1), and also by the quantities of particles regulated by the CaCO3–carrageenan content and the physicochemical microenvironment. The hybrid BC system can be considered as smart device since the kinetic release of doxorubicin from the hybrid cellulose system rise from 1.50 to 2.75 μg/membrane/day when the pH decreases from 7.4 to 5.8 at 37 °C, a pathologic simulated environment. The hybrid microparticle system can be potentially used as an implantable drug delivery system for personalized oncological therapies.
- 650 12
- $a celulosa $x biosyntéza $x farmakologie $7 D002482
- 650 12
- $a karagenan $x biosyntéza $x metabolismus $7 D002351
- 650 12
- $a uhličitan vápenatý $x chemická syntéza $x metabolismus $7 D002119
- 650 _2
- $a bakteriální polysacharidy $x biosyntéza $x farmakologie $x metabolismus $7 D011135
- 650 _2
- $a nanokompozity $x chemie $x mikrobiologie $x využití $7 D053761
- 650 _2
- $a Gluconacetobacter $x růst a vývoj $x účinky léků $7 D041821
- 650 _2
- $a systémy cílené aplikace léků $x metody $x využití $7 D016503
- 650 _2
- $a antitumorózní látky $x aplikace a dávkování $x terapeutické užití $x toxicita $7 D000970
- 650 _2
- $a doxorubicin $x aplikace a dávkování $x farmakologie $7 D004317
- 650 _2
- $a individualizovaná medicína $x metody $x trendy $x využití $7 D057285
- 650 _2
- $a spektrofotometrie infračervená $x metody $x využití $7 D013055
- 650 _2
- $a konfokální mikroskopie $x metody $x využití $7 D018613
- 650 _2
- $a elektronová mikroskopie $x metody $x využití $7 D008854
- 650 _2
- $a statistika jako téma $x metody $7 D013223
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a biomedicínský výzkum $x metody $x trendy $7 D035843
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Cesca, Karina $u Integrated Technologies Laboratory (InteLAB), CTC/EQA, Universidad Federal de Santa Catarina, Florianopolis, Brazil
- 700 1_
- $a Bosio, Valeria E. $u Nanobiomaterials Laboratory, Institute of Applied Biotechnology (CINDEFI, CONICET CCT La Plata), Department of Chemistry, School of Sciences, Universidad Nacional de La Plata, Calle 47 y 115, CP 1900, Ciudad de La Plata, Argentina
- 700 1_
- $a Porto, Luismar M. $u Integrated Technologies Laboratory (InteLAB), CTC/EQA, Universidad Federal de Santa Catarina, Florianopolis, Brazil
- 700 1_
- $a Castro, Guillermo R. $u Nanobiomaterials Laboratory, Institute of Applied Biotechnology (CINDEFI, CONICET CCT La Plata), Department of Chemistry, School of Sciences, Universidad Nacional de La Plata, Calle 47 y 115, CP 1900, Ciudad de La Plata, Argentina
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 13, č. 3 (2015), s. 239-248 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2015/03/09.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20150522215938 $b ABA008
- 991 __
- $a 20160131150402 $b ABA008
- 999 __
- $a ok $b bmc $g 1091016 $s 913168
- BAS __
- $a 3
- BMC __
- $a 2015 $b 13 $c 3 $d 239-248 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK184 $d 20160131 $a NLK 2015-40/dk